Gold Reserve Inc.: Publicly listed Venezuela recovery play

(Full access for Lifetime Members only)

Exclusive report for Lifetime Members only

Exclusive report for Lifetime Members only

Gold Reserve Inc.: Publicly listed Venezuela recovery play

17 March 2023

Placing a bet on Venezuela's recovery is anything but easy. Distressed government bonds are difficult to trade, and US citizens are even prohibited from investing in them. The local stock market is impossible to tap into for foreign private investors. Flying to Caracas to buy real estate is not exactly everyone's cup of tea, either.

The good news is, there is a way to benefit from a recovery in a way that is:

  • Easy: anyone with a brokerage account can buy and sell this security.
  • Compliant: even US citizens are allowed in, despite the sanctions regime.
  • Cheap: a lower valuation than that of other Venezuelan investments which specialist hedge funds have been mopping up.

There is also plenty of upside:

In a base-case scenario, this investment will rise in value by a factor of 2-3 over the course of 3-5 years (or even faster, with a bit of luck).

In a best-case scenario, it can increase tenfold – or even more.

In a worst-case scenario, investors probably still get about 50% of their money out.

That's what I call an asymmetrical play.

Crucially, on 15 March 2023, a catalyst became apparent that could give the Venezuelan turnaround a LOT of momentum in 2023 (possibly as early as the next few weeks).

At this stage, I am not going to reveal more about the details.

This opportunity is exclusively available to Lifetime Members.

Not a Lifetime Member yet? Sign up for a Membership - just USD 999/one-off.
Already a Lifetime Member? Log into your account to download the report.

Most recent

Latest reports (for Members only)

One of the world's best (and cheapest) oil and gas stocks

One of the world's best (and cheapest) oil and gas stocks

The stock of this oil and gas major has started to move, but it remains one of the cheapest large-cap stocks in the world.

Swiss takeover target

A bid waiting to happen

A takeover bid for this Swiss company should come in at least 40% above the current level. Now is the time to pick up stock at an attractive price.

Research Report Dr. Martens

Dr. Martens plc: marching towards turnaround

Successful, timeless brands don't come up for a discounted sale very often. Enter Dr. Martens – a true bargain for contrarian investors.